118 related articles for article (PubMed ID: 18941041)
1. Case report: Delayed enhancement on cardiac MRI in a patient with multiple myeloma without amyloidosis.
Brahmbhatt T; Hari P; Cinquegrani M; Kumar N; Komorowski R; Migrino RQ
Br J Radiol; 2008 Nov; 81(971):e272-5. PubMed ID: 18941041
[TBL] [Abstract][Full Text] [Related]
2. Cardiac amyloidosis in a patient with multiple myeloma: a case report and review of literature.
Sedaghat D; Zakir RM; Choe J; Klapholz M; Saric M
J Clin Ultrasound; 2009; 37(3):179-84. PubMed ID: 19177424
[TBL] [Abstract][Full Text] [Related]
3. Correlating multimodality imaging and pathological validation in heart failure.
O'Hanlon R; Heatlie G; Choudhury FJ; Price S; Prasad S; Sheppard M
JACC Cardiovasc Imaging; 2010 Oct; 3(10):1082-3. PubMed ID: 20947055
[No Abstract] [Full Text] [Related]
4. [Case of cardiac amyloidosis associated with IgG-K multiple myeloma in the framework of restrictive myocardiopathy].
Baldassarre S; Falsini G; Amidei S; Romei M; Forzoni M
Cardiologia; 1999 Feb; 44(2):193-7. PubMed ID: 10208058
[TBL] [Abstract][Full Text] [Related]
5. Late gadolinium enhancement magnetic resonance imaging in the diagnosis and prognosis of endomyocardial fibrosis patients.
Salemi VM; Rochitte CE; Shiozaki AA; Andrade JM; Parga JR; de Ávila LF; Benvenuti LA; Cestari IN; Picard MH; Kim RJ; Mady C
Circ Cardiovasc Imaging; 2011 May; 4(3):304-11. PubMed ID: 21415124
[TBL] [Abstract][Full Text] [Related]
6. Cardiac magnetic resonance imaging of eosinophilic endomyocardial disease.
Syed IS; Martinez MW; Feng DL; Glockner JF
Int J Cardiol; 2008 Jun; 126(3):e50-2. PubMed ID: 17399811
[TBL] [Abstract][Full Text] [Related]
7. Inversion time prolongation at late enhancement cardiac MRI in a myeloma patient.
Belloni E; Marchesi G; Aschieri D; Bernuzzi P; Trabacchi E; Vallisa D; Villani GQ; Cavanna L; Michieletti E
Diagn Interv Radiol; 2012; 18(6):552-4. PubMed ID: 23143894
[TBL] [Abstract][Full Text] [Related]
8. Images in cardiovascular medicine. Visualization of endomyocardial fibrosis by delayed-enhancement magnetic resonance imaging.
Cury RC; Abbara S; Sandoval LJ; Houser S; Brady TJ; Palacios IF
Circulation; 2005 Mar; 111(9):e115-7. PubMed ID: 15753221
[No Abstract] [Full Text] [Related]
9. An unusual association of endomyocardial fibrosis and hypertrophic cardiomyopathy in a patient with heart failure.
Salemi VM; D'andretta Iglezias S; Benvenuti LA; Filho JC; Rochitte CE; Shiozaki AA; Mady C
Cardiovasc Pathol; 2012; 21(2):e23-5. PubMed ID: 21641824
[TBL] [Abstract][Full Text] [Related]
10. Right ventricular endomyocardial fibrosis.
Mocumbi AO; Yacoub MH; Yokohama H; Ferreira MB
Cardiovasc Pathol; 2009; 18(1):64-5. PubMed ID: 18402830
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping.
Iles L; Pfluger H; Phrommintikul A; Cherayath J; Aksit P; Gupta SN; Kaye DM; Taylor AJ
J Am Coll Cardiol; 2008 Nov; 52(19):1574-80. PubMed ID: 19007595
[TBL] [Abstract][Full Text] [Related]
12. [Patterns of delayed-enhancement in MRI of ischemic and non-ischemic cardiomyopathies].
Stork A; Müllerleile K; Bansmann PM; Koops A; Meinertz T; Adam G; Lund GK
Rofo; 2007 Jan; 179(1):21-30. PubMed ID: 17203440
[TBL] [Abstract][Full Text] [Related]
13. Discrimination between pericardial disease and myocardial disease using tissue Doppler imaging in a patient with right-sided heart failure and multiple myeloma.
van Houwelingen KG; Bax JJ; Jukema JW; van der Wall EE
Int J Cardiovasc Imaging; 2003 Feb; 19(1):1-4. PubMed ID: 12602475
[TBL] [Abstract][Full Text] [Related]
14. Hypertrophic cardiomyopathy with restrictive phenotype and myocardial crypts.
Cannavale A; Ordovás KG; Rame EJ; Higgins CB
J Thorac Imaging; 2010 Nov; 25(4):W121-3. PubMed ID: 20463612
[TBL] [Abstract][Full Text] [Related]
15. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans.
Flett AS; Hayward MP; Ashworth MT; Hansen MS; Taylor AM; Elliott PM; McGregor C; Moon JC
Circulation; 2010 Jul; 122(2):138-44. PubMed ID: 20585010
[TBL] [Abstract][Full Text] [Related]
16. [Multiple myeloma manifesting as cardiac insufficiency].
Bennis A; Niang A; Lebbar K; Nafidi S; Zaid D; Tahiri A; Chraibi N
Ann Med Interne (Paris); 1999 Feb; 150(2):160-1. PubMed ID: 10392265
[No Abstract] [Full Text] [Related]
17. [Primary generalized amyloidosis with restrictive cardiomyopathy and severe chronic cardiac insufficiency].
Borovkov NN; Amineva NV; Kovaleva GV; Sal'tseva MT; Paĭkova NN; Kuznetsov SS
Klin Med (Mosk); 2009; 87(12):60-2. PubMed ID: 20135890
[TBL] [Abstract][Full Text] [Related]
18. An autopsy case of cardiomyopathy with restrictive physiology in a child.
Ishijima M; Kawai S; Okada R; Ino T; Yobuta K
Heart Vessels Suppl; 1990; 5():70-3. PubMed ID: 2093718
[TBL] [Abstract][Full Text] [Related]
19. Endomyocardial fibrosis: a restrictive cardiomyopathy in developing countries.
Vásquez-Rodríguez JF; Medina-Mur RI; Giraldo LE; Juan-Guardela ML; Gelves J; Jaimes CP
Arch Cardiol Mex; 2021; 91(2):196-201. PubMed ID: 33887758
[TBL] [Abstract][Full Text] [Related]
20. Case report: multiple myeloma presenting as a diastolic heart failure with no evidence of amyloidosis.
Schattner A; Epstein M; Berrebi A; Caspi A
Am J Med Sci; 1995 Dec; 310(6):256-7. PubMed ID: 7503107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
